Medifast, Inc.
MEDNYSEConsumer Cyclical● Active
$12.07
$-0.03(-0.25%)
Market Cap$134207537
P/E Ratio—
52W High$15.46
52W Low$9.22
Medifast, Inc. (MED) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MED · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.02B) | $0.00B | $0.10B | $0.14B | $0.16B |
| Depreciation & Amort. | $0.01B | $0.02B | $0.01B | $0.01B | $0.01B |
| Stock-Based Comp. | $0.01B | $0.01B | $0.01B | $0.01B | $0.01B |
| Change in Working Capital | ($0.01B) | ($0.01B) | $0.02B | $0.02B | ($0.09B) |
| Net Cash from Operations | $0.01B | $0.02B | $0.15B | $0.19B | $0.09B |
| Investing Activities | |||||
| Capital Expenditure | ($0.01B) | ($0.01B) | ($0.01B) | ($0.02B) | ($0.03B) |
| Purchases of Investments | ($0.08B) | ($0.05B) | ($0.05B) | $0.00B | $0.00B |
| Sales of Investments | $0.08B | $0.03B | $0.00B | $0.01B | $0.01B |
| Net Cash from Investing | ($0.01B) | ($0.03B) | ($0.06B) | ($0.01B) | ($0.03B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.00B) | ($0.00B) | ($0.01B) | ($0.13B) | ($0.06B) |
| Dividends Paid | ($0.00B) | ($0.00B) | ($0.07B) | ($0.07B) | ($0.06B) |
| Debt Issued / Repaid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Financing | ($0.00B) | ($0.00B) | ($0.08B) | ($0.20B) | ($0.13B) |
| Free Cash Flow | |||||
| Free Cash Flow | $0.00B | $0.02B | $0.14B | $0.18B | $0.06B |
| FCF Margin %(computed) | 0.32% | 2.83% | 13.17% | 11.13% | 3.95% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Medifast, Inc. data
About Medifast, Inc. (MED) Cash Flow Statement
Medifast, Inc. generated operating cash flow of $0.01B and free cash flow of $0.00B for 2025 — a FCF margin of 0.32%. Capital expenditure was ($0.01B).
Frequently asked questions
MED · 4 questionsMedifast, Inc. generated free cash flow of $0.00B for 2025, down 92.7% year-over-year.
MED free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10